Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to 'Letters to the Editor' comments on the paper 'Impact of positive surgical margins on biochemical recurrence and metastases after radical prostatectomy'.

BJU international·2026
Same author

Impact of Heterogeneous DNA Methylation on the Accuracy of Quantitative Methylation-Specific PCR for Detecting DNA Hypermethylation in Prostate Cancer.

International journal of molecular sciences·2026
Same author

Prostate cancer: Improving lives by not "overtreating" patients.

Central European journal of urology·2026
Same author

Impact of positive surgical margins on biochemical recurrence and metastases after radical prostatectomy.

BJU international·2026
Same author

Evaluating the Transition from 3D Laparoscopy to Robotic Partial Nephrectomy: Trifecta Achievement and Nephrometry Score Differences.

Cancers·2025
Same author

Would Biopsy Change the Management of Kidney Cancer in the Coming Decade? The Role of Biopsy in Small Renal Masses: A Narrative Review.

Cancers·2025

Related Experiment Video

Updated: May 14, 2026

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Predicting prostate biopsy outcome using a PCA3-based nomogram in a Polish cohort.

Maciej Salagierski1, Peter Mulders, Jack A Schalken

  • 1267 Experimental Urology, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, the Netherlands. J.Schalken@uro.umcn.nl

Anticancer Research
|February 9, 2013
PubMed
Summary

The Prostate Cancer Gene-3 (PCA3) score, combined with clinical factors, significantly improves prostate cancer (PCa) biopsy prediction compared to PCA3 or PSA alone.

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Related Experiment Videos

Last Updated: May 14, 2026

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization
07:34

Enhancing Prostate Tumor Biobanking Reliability with Improved Sampling Technique and Histological Characterization

Published on: November 17, 2023

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Area of Science:

  • Urology
  • Oncology
  • Biomarker Research

Background:

  • Prostate Cancer Gene-3 (PCA3) is a highly prostate cancer (PCa)-specific biomarker.
  • PCA3 shows promise for identifying men with PCa.

Purpose of the Study:

  • To evaluate the PCA3 score's ability to predict biopsy outcomes.
  • To assess if PCA3 can be used with clinical variables for PCa prediction.

Main Methods:

  • PCA3 scores were measured using the Progensa assay in 80 patients.
  • Logistic regression combined PCA3 with age, PSA, DRE, and prostate volume (Pvol).

Main Results:

  • Univariate analysis showed PCA3 outperformed other biopsy risk predictors.
  • A combined logistic regression model improved the ROC curve AUC from 0.72 (PCA3 alone) to 0.85.

Conclusions:

  • Integrating PCA3 with PCa risk factors significantly enhances the prediction of positive prostate biopsy results.
  • This combined approach offers superior predictive accuracy compared to using PCA3 or PSA alone.